Study finds higher risk of rare blood cancer after chemo - NCI

Study finds higher risk of rare blood cancer after chemo - NCI

5
(76)
Write Review
More
$ 6.00
Add to Cart
In stock
Description

An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia.

Blood Cancers: Types, Diagnosis, Prognosis

Leukemia: Symptoms, Signs, Causes, Types & Treatment

Blood test identifies acute myeloid leukemia patients at greater

Genetic profile predicts post-chemo cancer survival

Drug combination helps children with acute promyelocytic leukemia

NCI oral history: J. Palmer Saunders on being tasked to

NIH study finds that immunotherapy substantially increases

Secondary cancers following CAR T cell therapy are rare, analysis

Elevated Risk of Rare Blood Cancers after Chemotherapy - NCI

The 10 deadliest cancers, and why there's no cure

What Causes Leukemia after Breast Cancer? Research Shows That a

Study Finds Mysterious Rise In Childhood Cancer Rate - The New

Pediatric multicenter study shows targeted therapy for high-risk

Childhood Acute Lymphoblastic Leukemia Treatment - NCI

Is There a Cure for Cancer? Understanding the Latest Research